Skip to content
Buy This GLP
← Research
Evidence

Does a GLP-1 Shorten Your Hospital Stay After Surgery?

One lumbar fusion study found a shorter stay in patients with semaglutide prescriptions. Findings from other surgeries used different measures.

Editorial profile: Neil SandersBuy This GLP Editorial Team5 min read
After posterior cervical spine surgeryED visit, 90 days0.71admission, 90 days0.54complications at 90 daysno clear differencerevision and infection at 2 yearsno clear difference1,719 matched pairs, all without diabetes.

A shorter hospital stay can affect medical spending, but the length of stay and the patient’s bill are different outcomes. One study examined a lower-spine operation. People with a prior semaglutide prescription had shorter stays and lower costs [1].

What did researchers find after lumbar fusion?

Researchers compared 425 patients with active semaglutide prescriptions with 2,514 matched controls undergoing anterior lumbar interbody fusion. The stay was 0.6 days shorter on average. Same-day surgical costs were about $10,400 lower, and 90-day postoperative costs were about $9,700 lower. The study did not detect statistically clear differences in the measured complications at 90 days or two years [1].

Our breakdown of the lumbar fusion costs separates charges on the day of surgery from those in follow-up. The study used claims records. Patient selection or unmeasured surgical complexity could account for the differences. The study does not explain why costs differed.

How did other operations compare?

Our review of trigger finger studies looks at treatment and recovery after a different procedure. The studies below describe major operations and hospital outcomes.

Our review of a separate hip fracture registry examines complications and readmissions. Those outcomes answer different questions from the length of the initial hospital stay.

A posterior cervical spine study matched 1,719 people without diabetes who used a GLP-1 drug with 1,719 who did not. Within 90 days, the odds ratio for an emergency department visit was 0.71 (95% CI 0.58 to 0.87). The odds ratio for hospital admission was 0.54 (95% CI 0.41 to 0.70) [2]. Those figures count later encounters. They do not measure the length of the initial stay.

A study of femoral neck fracture repair included adults with type 2 diabetes. Researchers matched 112 GLP-1 users with 224 nonusers. It did not detect a statistically clear difference in length of stay[3]. The studies involved different operations and patient groups, so the lumbar fusion finding cannot predict recovery after other procedures.

What should I tell my surgical team?

Tell your surgical and anesthesia teams which medicine you take and when you last took it. The decision about managing a GLP-1 before surgery depends on factors such as your procedure, symptoms and reason for taking the drug. The hospital stay studies did not test whether continuing or pausing medication changes surgical outcomes [4].

Frequently asked

How much shorter was the hospital stay in the lumbar fusion study?
The initial stay was 0.6 days shorter on average in the group with semaglutide prescriptions. It was a retrospective study of one operation, so it cannot predict the length of your stay.
Did fewer admissions mean shorter stays after cervical surgery?
The cervical study counted hospital admissions and emergency visits in the 90 days after surgery. The reported odds ratios did not measure the length of the initial stay.

Sources

  1. [1] Ng MK, et al. (2026). Semaglutide Use Is Associated With Decreased Length of Stay and Hospital Costs in Patients Undergoing Anterior Lumbar Interbody Fusion: A Retrospective Cohort Study Orthopedics. PMID 41636429
  2. [2] Rivera NM, et al. (2026). The Impact of GLP-1 Receptor Agonists on Outcomes in Nondiabetic Patients Undergoing Posterior Cervical Spine Surgery: A Retrospective Analysis Clinical Spine Surgery. PMID 42615893
  3. [3] Box M, Puga T, Poffenbarger M, Liu Y, Riehl J (2026). Association of GLP-1 receptor agonist use with outcomes after surgical fixation of femoral neck fracture in patients with type 2 diabetes: a propensity score-matched analysis European Journal of Orthopaedic Surgery & Traumatology. PMID 41870668
  4. [4] American Diabetes Association Professional Practice Committee for Diabetes (2026). Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 Diabetes Care. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence